Baricitinib possible therapeutic option for children with AD Presented ByDr Antonio Torrelo Fernández, Hospital Infantil Universitario Niño Jesús, Spain TrialPhase 3, BREEZE-AD-PEDS ConferenceEADV 2022 5 November, 2022 09:15